1. Slide 1 Presented By Jan Buckner at 2014 ASCO Annual Meeting

2. Slide 2 Presented By Jan Buckner at 2014 ASCO Annual Meeting

3. No Disclosures Presented By Jan Buckner at 2014 ASCO Annual Meeting

4. Responses to Chemotherapy in Recurrent Low-grade Glioma Patients Presented By Jan Buckner at 2014 ASCO Annual Meeting

5. PCV for newly diagnosed Grade 2 O/OA Presented By Jan Buckner at 2014 ASCO Annual Meeting

6. R9802 SCHEMA Presented By Jan Buckner at 2014 ASCO Annual Meeting

7. Key Eligibility Criteria Presented By Jan Buckner at 2014 ASCO Annual Meeting

8. Pretreatment Patient Characteristics Demographic Factors Presented By Jan Buckner at 2014 ASCO Annual Meeting

9. Pretreatment Patient Characteristics Functional Status Presented By Jan Buckner at 2014 ASCO Annual Meeting

10. Pretreatment Patient Characteristics Surgery and Histology Presented By Jan Buckner at 2014 ASCO Annual Meeting

11. Data Maturity Presented By Jan Buckner at 2014 ASCO Annual Meeting

12. Slide 12 Presented By Jan Buckner at 2014 ASCO Annual Meeting

13. ASCO 2014: Progression-Free Survival Presented By Jan Buckner at 2014 ASCO Annual Meeting

14. Progression-Free Survival ASCO 2014 Presented By Jan Buckner at 2014 ASCO Annual Meeting

15. Slide 15 Presented By Jan Buckner at 2014 ASCO Annual Meeting

16. ASCO 2014: Overall Survival Presented By Jan Buckner at 2014 ASCO Annual Meeting

17. Overall Survival ASCO 2014 Presented By Jan Buckner at 2014 ASCO Annual Meeting

18. Salvage Treatment Presented By Jan Buckner at 2014 ASCO Annual Meeting

19. Cox Proportional Hazards Model for Progression Free Survival (n=251) Presented By Jan Buckner at 2014 ASCO Annual Meeting

20. Cox Proportional Hazards Model for Overall Survival (n=251) Presented By Jan Buckner at 2014 ASCO Annual Meeting

21. Constitutional Toxicity Presented By Jan Buckner at 2014 ASCO Annual Meeting

22. Hematologic Toxicity Presented By Jan Buckner at 2014 ASCO Annual Meeting

23. Gastrointestinal Tract Toxicity Presented By Jan Buckner at 2014 ASCO Annual Meeting

24. Late Radiotherapy Toxicity Presented By Jan Buckner at 2014 ASCO Annual Meeting

25. Categorical Change in MMSE Score by Treatment Arm Presented By Jan Buckner at 2014 ASCO Annual Meeting

26. Conclusions (Survival) Presented By Jan Buckner at 2014 ASCO Annual Meeting

27. Conclusions (Prognostic Variables) Presented By Jan Buckner at 2014 ASCO Annual Meeting

28. Conclusions (Toxicity) Presented By Jan Buckner at 2014 ASCO Annual Meeting

29. Conclusions (Trial Conduct) Presented By Jan Buckner at 2014 ASCO Annual Meeting

30. Future Plans Presented By Jan Buckner at 2014 ASCO Annual Meeting

31. Acknowledgements Presented By Jan Buckner at 2014 ASCO Annual Meeting

32. Slide 32 Presented By Jan Buckner at 2014 ASCO Annual Meeting

33. Back Up Slides Presented By Jan Buckner at 2014 ASCO Annual Meeting

34. Radiotherapy Review Presented By Jan Buckner at 2014 ASCO Annual Meeting

35. Chemotherapy Review Presented By Jan Buckner at 2014 ASCO Annual Meeting